Oral Dissolving Film Manufacturing FAQ

A thin polymer-based film designed to disintegrate in the mouth without water. Depending on the formula and market classification, it may deliver dietary, botanical, oral-care or pharmaceutical ingredients.

No. Oral dissolving films are placed in the mouth and dissolve. Whitening strips adhere to teeth and are removed; they are a different product category.

There is no single universal time. Film size, thickness, polymer system, saliva exposure and active loading all influence disintegration. A target is agreed and verified during development.

Loading depends on solubility, particle properties, taste, film area and the required mechanical strength. High-dose concepts may require a larger film, multiple units or a different dosage form.

Private-label platforms usually allow lower MOQs than custom formulas. Printed sachet and carton minimums, testing and ingredient procurement often determine the final commercial MOQ.

These positions can be evaluated through ingredient and processing-aid review. Final claims require confirmation against the full formula and supplier documentation.

Common directions include mint, berry, watermelon, citrus and peach. Flavor selection is linked to active taste, sweetener system and target consumer.

Prescription and smoking-cessation medicines require an appropriately licensed pharmaceutical CDMO, registrations and market authorization. Ordinary supplement manufacturing cannot lawfully substitute for that pathway.

Target market, product concept, ingredients and per-strip dosage, flavor, pack count, annual forecast, desired launch date and any required certifications.

We can design formulas and documentation around a target market, but final classification, label and claims should be confirmed by qualified local regulatory counsel or the responsible market operator.

Qualify the manufacturer against your exact product brief. Ask who formulates, coats, cuts, tests and packs the films, and which operations are subcontracted. Request a representative batch record, sample COA, traceability example and documented complaint procedure. Verify that any certificate applies to the legal entity, manufacturing site and activity involved. Compare how suppliers explain loading limits and sample failures; a credible technical discussion is more useful than an unqualified promise to manufacture any formula.

Private label commonly uses an existing formula with your brand and packaging. An OEM arrangement generally manufactures to an agreed specification, while ODM usually includes formulation or product design by the supplier. These terms are used differently across suppliers, so the contract should define the actual deliverables: formula development, testing, artwork, manufacturing, documentation and ownership. Choose based on the degree of differentiation you need and the responsibilities your team can manage.

Compare quotes for the same active amount, strips per serving, strips per box and packaging specification. Separate one-time development and testing charges from repeat production costs. Ask whether the price includes printed sachets, cartons, release testing, freight and applicable duties, and identify the delivery terms. For example, a 20-strip box and a 30-strip box are not equivalent quotes. Compare the cost per accepted saleable strip and document how rejects, overruns and artwork changes are charged.

Request a milestone-based schedule after the technical brief is reviewed. Distinguish a sample of an existing platform from a prototype containing your exact ingredients and dose. Raw-material procurement, method development, bitterness, film brittleness, printed packaging and repeated formulation trials can extend the schedule. Ask which milestones depend on your approval and whether stability work continues after initial sampling. A prototype dispatch date is not the same as a confirmed commercial production or market-launch date.

Agree on written acceptance criteria before evaluating samples. Check whether each strip releases cleanly from its sachet, can be handled without tearing, and meets the agreed appearance, dimensions, mouthfeel and disintegration target. Request analytical results appropriate to the formula, including active content and uniformity where relevant. Record sample version, batch number, packaging and storage conditions. Keep an approved reference sample, and make clear that sensory approval alone does not release a commercial batch.

Treat conversion as a new formulation project rather than a direct transfer. Review the amount required per daily serving, ingredient bulk, taste and compatibility with film processing. A formula that works in several capsules or gummies may not fit comfortably in one strip. Development may require a revised serving size, a simpler ingredient system or a different format. Compare the proposed finished product with the original commercial brief before approving changes to ingredient amounts or positioning.

Ownership depends on the written agreement, not on the label OEM or ODM. Before sharing a detailed brief, define confidentiality and separate the supplier’s existing technology from work created for your project. Agree who owns the formulation, test methods, specifications, artwork and tooling, and whether any exclusivity applies by territory or product. Also clarify whether you can obtain the technical documents needed to transfer production later. Development fees alone do not establish formula ownership.

A useful COA identifies the finished product, batch, specification version and release decision. For each reported test, look for the method reference, acceptance limit and result rather than a generic statement that the product passed. Appropriate items may include active identity or assay, microbiological limits, moisture and relevant contaminants, depending on the formula and market. Ask which tests are performed per batch and which rely on a justified periodic program. A raw-material COA does not replace finished-product release evidence.

Select packaging together with the formula and planned distribution conditions. Individually sealed barrier sachets are a common starting point, but the laminate and seal need to protect the actual product. Ask how the supplier checks seal integrity and monitors packaged films over time. Confirm storage instructions and shipping exposure limits using the agreed evidence. Do not assume that a shelf life established for one formula or sachet also applies after ingredients, packaging materials or pack configuration change.

Use an approved master specification, reference sample and documented change-control process. Agree which raw materials, formula, film dimensions, packaging and analytical methods are fixed, and which changes require buyer approval. During scale-up, compare pilot and production results against agreed criteria rather than appearance alone. For repeat orders, request batch identification, release documentation and confirmation of any changes. Define investigation and corrective-action responsibilities so a complaint leads to traceable follow-up across affected batches.